...
首页> 外文期刊>Vaccine >Immunogenicity and safety of low dose virosomal adjuvanted influenza vaccine administered intradermally compared to intramuscular full dose administration
【24h】

Immunogenicity and safety of low dose virosomal adjuvanted influenza vaccine administered intradermally compared to intramuscular full dose administration

机译:与肌肉内全剂量给药相比,皮内注射低剂量病毒体佐剂型流感疫苗的免疫原性和安全性

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Despite the established benefit of intramuscular (i.m.) influenza vaccination, new adjuvants and delivery methods for comparable or improved immunogenicity are being explored. Intradermal (i.d.) antigen administration is hypothesized to initiate an efficient immune response at reduced antigen doses similar to that observed after i.m. full dose vaccination. METHODS: In a randomized, partially blinded phase II study 224, healthy adults aged >/=18 to
机译:背景:尽管肌内(i.m.)流感疫苗接种具有确定的益处,但仍在探索新的佐剂和可比较或改善的免疫原性的递送方法。假定皮内(i.d.)抗原施用以降低的抗原剂量启动有效的免疫反应,该剂量与在i.m.之后观察到的相似。全剂量疫苗接种。方法:在一项随机,部分不知情的II期研究224中,年龄≥/ = 18至

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号